Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Terrific news!
View:
Post by riverrrow on Sep 27, 2023 9:40am

Terrific news!

And so far the price remains flat with no volume.  With a second cancer treatment now on its way TLT market cap should be double.  Knowing  TLT's trading history, TLT will close down today.
Comment by anabelsi on Sep 27, 2023 10:02am
This is depressing, I am starting to worry that the SP won't move up even if we get BTD... It makes no sense to me, there are way worse companies with nothing of substance and they have a better stock price, but a company with an excellent cancer treatment is in the 0.2s????
Comment by StevenBirch on Sep 27, 2023 10:36am
No if anything it proves what we have been saying the last couple of days, because this IS good news but only 2 things will move the price - a deal of some sort or aprroval from the FDA. Some wanted Roger to put their mind at ease with this little selloff, is this it or just coincidence? All I know is they seem to have big plans and it will take money, they must have SOME idea when and where it ...more  
Comment by anabelsi on Sep 27, 2023 11:14am
Yeah you are right, thanks Steven.
Comment by StevenBirch on Sep 27, 2023 11:36am
I don't know if I'm 100% right and I felt the exact same way you did yesterday but I just don't want to see anyone get hurt by these manipulative games in the market. I used to think these people would make a few pennies and build their position while we waited but now I think they are even willing to lose a few pennies to increase their position. Even that could be a sign of how close ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250